In Phase II Clinical Trials
Development of Effective and Innovative Medicines to Address the needs of Patients and Improve their Health, Longevity and Quality of Life.
Message: Bizarre trading
Generic_profile
Rank: [?]
Mail Room
Points: [?]
67
Rating: [?]
Votes: 2 Score: 3.5
  • Currently 3.5/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Bizarre trading

in response to Re: Bizarre trading by markak15
posted on Oct 01, 08 12:30PM

The reverse split would be fine by me.

A few years ago I owned Able Laboratories, a generic pharmaceutical company.

I bought them in the .33 to .41 range and they did a 15/1 reverse split (around $4) in order to achieve a NASDAQ listing.

Eventually Ables price rose to $22+ per share.

However, due to quality control issues with there product and litigation Able ended up going out of business.


New Message

Please login to post a reply

Executive Address
Alrxsmall
Michael Lee
President
May 18, 2006

 

Michael Lee provides the investor community an update on recent events

View Broadcast

Stock Quote